These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18083549)

  • 61. Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo.
    Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    J Immunol Res; 2020; 2020():3194704. PubMed ID: 32411793
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
    Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
    BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
    Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
    Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.
    Christensen ND; Reed CA; Cladel NM; Han R; Kreider JW
    J Virol; 1996 Feb; 70(2):960-5. PubMed ID: 8551636
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural insight into the type-specific epitope of porcine circovirus type 3.
    Bi M; Li X; Zhai W; Yin B; Tian K; Mo X
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458997
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation.
    Pitoiset F; Vazquez T; Levacher B; Nehar-Belaid D; Dérian N; Vigneron J; Klatzmann D; Bellier B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794025
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins.
    Visciano ML; Diomede L; Tagliamonte M; Tornesello ML; Asti V; Bomsel M; Buonaguro FM; Lopalco L; Buonaguro L
    Vaccine; 2011 Jul; 29(31):4903-12. PubMed ID: 21596074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
    Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP
    Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits.
    Cheong WS; Hyakumura M; Yuen L; Warner N; Locarnini S; Netter HJ
    Antiviral Res; 2012 Feb; 93(2):209-218. PubMed ID: 22138713
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.
    Boigard H; Cimica V; Galarza JM
    Vaccine; 2018 Nov; 36(50):7728-7736. PubMed ID: 30377067
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
    Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
    Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.
    Tegerstedt K; Franzén AV; Andreasson K; Joneberg J; Heidari S; Ramqvist T; Dalianis T
    Anticancer Res; 2005; 25(4):2601-8. PubMed ID: 16080500
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques.
    Weiwei G; Xuexing Z; Chong W; Yongkun Z; Qi W; Hualei W; Gary W; Ying X; Haijun W; Zengguo C; Na F; Hang C; Tiecheng W; Yuwei G; Junjie S; Songtao Y; Xianzhu X
    J Med Virol; 2017 Dec; 89(12):2069-2074. PubMed ID: 28402024
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine.
    Emeny RT; Wheeler CM; Jansen KU; Hunt WC; Fu TM; Smith JF; MacMullen S; Esser MT; Paliard X
    J Virol; 2002 Aug; 76(15):7832-42. PubMed ID: 12097595
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology.
    Wang X; Sapp M; Christensen ND; Dillner J
    J Gen Virol; 2005 Jan; 86(Pt 1):65-73. PubMed ID: 15604432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
    Hendin HE; Pillet S; Lara AN; Wu CY; Charland N; Landry N; Ward BJ
    Vaccine; 2017 May; 35(19):2592-2599. PubMed ID: 28389100
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases.
    Tariq H; Batool S; Asif S; Ali M; Abbasi BH
    Front Microbiol; 2021; 12():790121. PubMed ID: 35046918
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Virus-Like Particles as an Instrument of Vaccine Production.
    Syomin BV; Ilyin YV
    Mol Biol; 2019; 53(3):323-334. PubMed ID: 32214478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.